Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Experimentelle and Diagnostische Immunologie

Experimentelle and Diagnostische Immunologie?uq=UG6efJS6
1996 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of human organotypic (HOT) cell culture test systems intended to mimic particular human organ systems. The company's human organotypic (HOT) cell culture test systems with complex co-culture systems and has proprietary technologies that are unparalleled in generating quality, reproducible data for drug development applications enabling businesses to grow cells under controlled conditions, generally outside of their natural environment.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Primary Office
  • Aspenhaustr. 25
  • 72770 Reutlingen
  • Germany

Experimentelle and Diagnostische Immunologie Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Experimentelle and Diagnostische Immunologie‘s full profile, request access.

Request full access to PitchBook

Experimentelle and Diagnostische Immunologie Executive Team (1)

Name Title Board
Seat
Contact
Info
Manfred Schmolz Founder & General Manager